Innovation at the Intersection of Clinical Trials and Real‐World Data Science to Advance Patient Care

While efficacy and safety data collected from randomized clinical trials are the evidentiary standard for determining market authorization, this alone may no longer be sufficient to address the needs of key stakeholders (regulators, providers, and payers) and guarantee long‐term success of pharmaceu...

Descripción completa

Detalles Bibliográficos
Autores principales: Swift, Brandon, Jain, Lokesh, White, Craig, Chandrasekaran, Vasu, Bhandari, Aman, Hughes, Dyfrig A., Jadhav, Pravin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132367/
https://www.ncbi.nlm.nih.gov/pubmed/29768712
http://dx.doi.org/10.1111/cts.12559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132367/
https://www.ncbi.nlm.nih.gov/pubmed/29768712
http://dx.doi.org/10.1111/cts.12559

Ejemplares similares